Tumor necrosis factor-α -863 C/A promoter polymorphism affects the inflammatory response after cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages

  Boehm, Johannes ^a   Hauner, Katharina ^a   Grammer, Joachim ^a   Dietrich, Wulf ^a   Wagenpfeil, Stefan ^a   Braun, Siegmund ^a   Lange, Rüdiger ^a   Bauernschmitt, Robert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiopulmonary bypass; Genetic polymorphisms; Inflammation; TNF

Indexed keywords

CARRIER PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ARTICLE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MIDDLE AGED; PERIOPERATIVE CARE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957980731     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.01.084     Document Type: Article

References (25)

1. Butler J., Parker D., Pillai R., Westaby S., Shale D.J., Rocker G.M. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993, 105:25-30.
2. Podgoreanu M.V., Schwinn D.A. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol 2005, 46:1965-1977.
3. Gaudino M., Andreotti F., Zamparelli R., Di C.A., Nasso G., Burzotta F., Iacoviello L., Donati M.B., Schiavello R., Maseri A., Possati G. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 2003, 108(Suppl. 1):II195-II199.
4. Gaudino M., Di Castelnuovo A., Zamparelli R., Andreotti F., Burzotta F., Iacoviello L., Glieca F., Alessandrini F., Nasso G., Donati M.B., Maseri A., Schiavello R., Possati G. Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery. J Thorac Cardiovasc Surg 2003, 126:1107-1112.
5. Grunenfelder J., Umbehr M., Plass A., Bestmann L., Maly F.E., Zund G., Turina M. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2004, 128:92-97.
6. Podgoreanu M.V., White W.D., Morris R.W., Mathew J.P., Stafford-Smith M., Welsby I.J., Grocott H.P., Milano C.A., Newman M.F., Schwinn D.A. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006, 114(1 Suppl.):I275-I281.
7. Bittar M.N., Carey J.A., Barnard J.B., Pravica V., Deiraniya A.K., Yonan N., Hutchinson I.V. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg 2006, 81:132-137.
8. Misoph M., Babin-Ebell J. Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 1997, 12:119-127.
9. Rothenburger M., Soeparwata R., Deng M.C., Schmid C., Berendes E., Tjan T.D., Wilhelm M.J., Erren M., Bocker D., Scheld H.H. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 2001, 16(Suppl. 1):44-50.
10. Hennein H.A., Ebba H., Rodriguez J.L., Merrick S.H., Keith F.M., Bronstein M.H., Leung J.M., Mangano D.T., Greenfield L.J., Rankin J.S. Relationship of the proinflammatory cytokines to myocardial ischemia. J Thorac Cardiovasc Surg 1994, 108:626-635.
11. Strieter R.M., Kunkel S.L., Bone R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993, 21(10 Suppl.):S447-S463.
12. Bayley J.P., de Rooij H., van den Elsen P.J., Huizinga T.W., Verweij C.L. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001, 14:316-323.
13. Yoon S.Z., Jang I.-J., Choi Y.J., Kang M.H., Lim H.J., Lim Y.J., Lee H.W., Chang S.H., Yoon S.M. Association between tumor necrosis factor α 308G/A polymorphism and increased proinflammatory cytokine release after cardiac surgery with cardiopulmonary bypass in the Korean population. J Cardiothorac Vasc Anesth 2009, 23:646-650.
14. Galinanes M., James M., Codd V., Baxi A., Hadjinikolaou L. TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment. Eur J Cardiothorac Surg 2008, 34:332-337.
15. Skoog T., van't Hooft F.M., Kallin B., Jovinge S., Boquist S., Nilsson J., Eriksson P., Hamsten A. A common functional polymorphism (C>A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999, 8:1443-1449.
16. Ramos E.M., Lin M.T., Larson E.B., Maezawa I., Tseng L.H., Edwards K.L., Schellenberg G.D., Hansen J.A., Kukull W.A., Jin L.W. Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 2006, 63:1165-1169.
17. Chen Y.C., Liu S.F., Chin C.H., Wu C.C., Chen C.J., Chang H.W., Wang Y.H., Chung Y.H., Chao T.Y., Lin M.C. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease. Lung 2010, 188:339-347.
18. Heesen M., Kunz D., Wessiepe M., van der Poll T., Zwinderman A.H., Blomeke B. Rapid genotyping for tumor necrosis factor-{alpha} (TNF-{alpha}) -863C/A promoter polymorphism that determines TNF-{alpha} response. Clin Chem 2004, 50:226-228.
19. Martinez-Comendador J.M., Alvarez J.R., Mosquera I., Sierra J., Adrio B., Carro J.G., Fernandez A., Bengochea J. Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery. Eur J Cardiothorac Surg 2009, 36:998-1005.
20. Yende S., Quasney M.W., Tolley E., Zhang Q., Wunderink R.G. Association of tumor necrosis factor gene polymorphisms and prolonged mechanical ventilation after coronary artery bypass surgery. Crit Care Med 2003, 31:133-140.
21. Mira J.P., Cariou A., Grall F., Delclaux C., Losser M.R., Heshmati F., Cheval C., Monchi M., Teboul J.L., Riche F., Leleu G., Arbibe L., Mignon A., Delpech M., Dhainaut J.F. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999, 282:561-568.
22. Stuber F., Udalova I.A., Book M., Drutskaya L.N., Kuprash D.V., Turetskaya R.L., Schade F.U., Nedospasov S.A. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995, 46:42-50.
23. Chen Y.F., Jobanputra P., Barton P., Jowett S., Bryan S., Clark W., Fry-Smith A., Burls A. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006, 10:1-229.
24. Maekawa N., Wada H., Kanda T., Niwa T., Yamada Y., Saito K., Fujiwara H., Sekikawa K., Seishima M. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-{alpha}. J Am Coll Cardiol 2002, 39:1229-1235.
25. Zhang C., Wu J., Xu X., Potter B.J., Gao X. Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol 2010, 105:453-464.